A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

NCT03816176 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Mucormycosis
Invasive Aspergillosis

Interventions

DRUG: Isavuconazonium sulfate
DRUG: Isavuconazonium sulfate

Sponsor

Astellas Pharma Global Development, Inc.